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Abstract Pancreatic metallocarboxypeptidases are inhibited by 
a millimolar excess of zinc together with other exo- and 
endometalloproteases. We have analyzed the structure of bovine 
carboxypeptidase A inhibited by an excess of zinc ions using X-
ray crystallography at 1.7 A overall resolution. Under these 
conditions, a second zinc is observed to bind to the enzyme active 
site, establishing a distorted tetrahedrally coordinated complex 
which involves Glu-270 (the general base for catalysis), a water 
molecule, a chloride ion, and a hydroxide ion. This hydroxide ion 
forms a 114° angular bridge between the inhibitory and the 
catalytic zinc ions, which are at a distance of 3.3 A from one 
another. The inhibitory zinc holds the hydroxide at nearly the 
same location as a previously observed active site water molecule 
(W571) and probably perturbs the substrate positioning and 
stereochemical rearrangements required for substrate cleavage 
during catalysis. 
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1. Introduction 
Carboxypeptidase A (CPA, EC 3.4.17.1) is a zinc metal-
loenzyme that catalyses the hydrolysis of C-terminal residues 
from peptide or ester substrates by cleavage of the peptide or 
ester bond [1,2]. One Zn2+ ion is strongly coordinated at the 
active site and is involved in catalysis [2]. CPA has been the 
subject of a large number of biochemical and crystallographic 
studies both in its free state and bound to peptidic and pepti-
domimetic inhibitors [2,3]. Additionally, the interactions of 
the enzyme with its 95-residue activation segment in the cat-
alytically inactive procarboxypeptidase A [4], and with the 
specific protein inhibitor isolated from potato [5], have been 
analysed in depth [6]. 
Within a few years of finding that CPA is a zinc-dependent 
enzyme [7], it was reported that millimolar concentrations of 
ZnCI2 inhibit its hydrolytic activity in a competitive way for 
both ester and peptide substrates [8]. These results were later 
corroborated by equilibrium dialysis experiments, indicating 
that CPA loosely binds a second equivalent of zinc in the pH 
range from 7 to 10 [9,10]. Additional evidence was obtained 
by stopped-flow and spectrophotometric methods using the 
derivatized azo-carboxypeptidase A [11]. From these experi-
ments, it was not possible to locate precisely the binding site 
of the excess zinc ions but the results suggested that the zinc 
binding site for inhibition was not far from the enzyme active 
site but did not involve the substrates. 
Later, using kinetic approaches, Larsen and Auld studied 
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the state(s) of hydroxylation of the inhibitory zinc and its 
possible site(s) of interaction with CPA [12]. The authors 
showed that the pH dependence of the pKi follows a pattern 
which indicates that the enzyme is selectively inhibited by zinc 
monohydroxide, ZnOH+ (Ki = 7.1 X 10-7 M). Furthermore, 
they postulated that the ionization of a ligand in the enzyme's 
inhibitory site should be obligatory for binding of ZnOH+ to 
the complex and, after kinetic studies of the pH dependence of 
substrate hydrolysis, they proposed that the inhibitory zinc 
ion binds to the carboxylate of Glu-270. Also, they suggested 
that the inhibition process is specific for zinc monohydroxide 
because it allows the formation of a stabilizing hydroxide 
bridge between the inhibitory and catalytic zinc ions. The 
latter was corroborated in further studies [13] where the 
mode of interaction for several inhibitory metal ions (Zn2+, 
Pb2+, and Cd2+) with Glu-270 was investigated by the specific 
chemical modification of this residue. Finally, a novel type of 
metal binding site based on a bridging interaction between the 
Glu-270-coordinating metal hydroxide and the catalytic metal 
ion was proposed. 
Besides CPA, several zinc proteases have been shown to be 
inhibited by excess zinc, e.g. thermolysin [14], the neutral me-
tallo-endopeptidase from rabbit kidney brush border [15], hu-
man neutrophil collagenase [16], and angiotensin converting 
enzyme [17], among others. However, except for the endopro-
teinase thermo lysin [18], none of these enzymes have been 
studied by X-ray crystallography to confirm the biochemical 
data. The present work reports the structural features of the 
complex of bovine CPA with two zinc ions as derived by X-
ray crystallography. These features clarify the inhibitory effect 
of excess zinc ions in CPA, and suggest a general structural 
model for this type of inhibition in zinc-dependent metallo-
proteases. 
2. Materials and methods 
Bovine CPA was purchased from Sigma and used without further 
purification. Crystals for the collection of X-ray data were prepared 
using the dialysis method proposed by Coleman and Vallee [9]. Ac-
cordingly, a solution containing 5 mg/ml CPA in I M LiCI, 0.02 M 
Tris-HCI, at 7.5, was dialyzed, using membrane dialysis tubes, against 
a solution of 0.5 M in LiCI, buffered with 0.02 M Tris to pH 7.5. In a 
second step, the protein in the membrane dialysis tube was equili-
brated against 0.25 M LiCI with the same buffer for 2 days at 4°C. 
At this point tiny crystals appeared in the dialysis tube, which grew 
without further stirring to the maximal dimensions of 2 x 0.5 x 0.2 
mm3 after 3 or 4 days of equilibration. 
Some of the crystals were separated for subsequent control of the 
enzymatic activity, the rest of the crystal suspension being equilibrated 
by dialysis against 0.33 mM ZnCh, 0.25 M in LiCl, buffered with 0.02 
M Tris-HCI to pH 7.5, in order to obtain CPA+Zn crystals [12]. 
The CPA activity of the crystals in the presence and absence of zinc 
was analyzed, after dissolution, using hippuryl-L-phenylalanine (HPA) 
(supplied by Sigma) as a substrate by monitoring the increase in 
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absorbance at 254 nm, according to the procedure of Sebastian [19]. 
Six crystals of native CPA and of CPA+Zn were washed with 0.25 M 
LiCI, 0.02 M Tris-HCI (pH 7.5) and dissolved in I M LiCI, 0.02 M 
Tris-HCI, pH 7.5. The dissolved CPA+Zn crystals showed only 2% 
residual activity as compared with the native enzyme crystals, in ac-
cordance with previous studies [12]. 
A complete data set of CPA+Zn X-ray diffraction intensities up to 
1.7 A was recorded at a 100 mm crystal-to-detector distance on a 300-
mm MAR Research Imaging plate detector attached to a Rigaku-
Denki RU200 rotating CuKa-anode X-ray generator, operated at 
5.4 kW, and at 10°C. The diffraction data were processed with 
MOSFLM v 5.23 [20] and scaled, merged, and reduced using pro-
grams of the CCP4 package [21]. Table I provides a summary of 
the data collection and processing. The space group is P2 j with lattice 
constants a==46.45, b==59.55, c==51.23 and ~==97.40° compared to 
a = 51.60, b == 60.27, c = 47.25 and ~ == 97.27° of the native enzyme 
[3]. The coordinates of the protein part of native CPA available 
from the Protein Data Bank (PDB access code 5cpa [3]) were used 
to solve the structure. The coordinates were submitted to rigid-body 
and positional refinements followed by a temperature factor refine-
ment using X-PLOR [22]. After this, the crystallographic R factor 
dropped from 31.2 to 26.2. The resulting model was inspected and 
corrected manually against (2Fobs-Fcalc) and (Fobs-Fcalc) Fourier 
maps, including water molecules at stereochemically reasonable posi-
tion using TURBO Frodo (version 5.0a, Biographics, Marseille) on a 
Silicon Graphics workstation. In the vicinity of Glu-270, the catalytic 
base of the enzyme located close to the active-site zinc ion, clear 
(positive) electron density was observed in both Fourier map types 
which was assigned to a second zinc ion and a chloride ion. The new 
model was further submitted to crystallographic refinement, with a 
final R factor of 0.187 and refined against 27835 reflections in the 
range 6.0 A to 1.7 A. 
The final model comprises the 307 residues of CPA (labelled 1-307), 
192 solvent molecules (labelled W308-W500), two zinc ions (labelled 
998 and 999) and one chloride anion Cl-(501). An inspection of the 
Ramachandran plot reveals one residue in a disallowed region: Ser-
199, unambiguously defined by electron density and with similar 
main-chain angles to those described for the native CPA structure. 
Both figures (I and 2) are presented in the standard orientation, i.e. 
looking into the active-site cleft with the catalytic (and inhibitory) zinc 
ions with a putative substrate binding horizontally from left (N-ter-
minally from the scissile peptide bond) to right (C-terminus with the 
hydrophobic SI' pocket). 
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The final coordinates will be deposited with the Brookhaven Protein 
Data Bank. 
3. Results and discussion 
3.1. Three-dimensional crystal structure of CPA+Zn 
The binding of a second zinc ion to bovine CPA does not 
significantly alter the basic crystallographic parameters or the 
overall three-dimensional structure of the enzyme (Fig. 1). 
The spatial locations of all the protein residues of the active 
site of CPA, except Glu-270, are virtually in the same position 
in the crystal structures of the active enzyme and of the zinc-
inhibited enzyme. As seen previously [3], the catalytic zinc ion 
is coordinated in CPA by the side chains of His-69, Glu-n, 
His-I96, and by an active-site water molecule (W571). Close 
to these are the residues involved in catalysis and substrate 
binding, which have been classified in five subsites, SI'-S4 
[3,6,23): Glu-270, Arg-I27, Asn-I44, Arg-145, Tyr-248, Arg-
71, Ser-197, Tyr-198, Ser-199, etc. In the standard mechanism 
of CPA it is proposed that the nucleophilic attack on the 
scissile peptide carbonyl of the substrate is made by the co-
ordinated water molecule (W571) which is polarised by the 
zinc and whose proton is abstracted by Glu-270, the general 
base [2). The oxyanion of the resulting tetrahedral intermedi-
ate is stabilized by the zinc ion and by Arg-127. Subsequently, 
a proton is transferred from Glu-270 to the imino group of 
the substrate peptide bond, which is cleaved. 
In the first Fourier map (2Fo-Fe and Fo-Fe) obtained 
from the CPA+Zn crystal the inhibitory zinc ion (998 num-
bering in our model) was identified by a strong electron den-
sity (5a, with a temperature factor of B = 23 }..2 after final 
refinement). This second zinc ion is located 3.3 }... from the 
catalytic zinc (999) (and exhibits a temperature factor B = 11 
}...2). The catalytic water has been slightly displaced by the 
inhibitory zinc from its original position, and because of its 
Fig. I. Ribbon diagram [24] showing the backbone of bovine carboxypeptidase A in the presence of excess zinc. Black spheres represent the 
two zinc ions bound to the active site. The amino acid residues coordinating both zinc ions are shown in ball-and-stick representation: His-69, 
Glu-72 and His-296 coordinate the catalytic zinc and Glu-270 the inhibitory zinc. 
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Fig. 2. Stereo drawing showing a region of the (2Fo-Fc, contoured at Icr) difference map of the carboxypeptidase A+excess zinc crystal struc-
ture including the main residues of the active site region, the two zinc ions, the coordinating water/hydroxide and water molecules, and the 
chloride ion. 
close proximity to both zinc ions (2.36 and 2.17 A.., see Table 
2) it is probably a hydroxide ion and establishes a bridge 
between the cations with a Zn-O-Zn angle of 114°. The in-
hibitory zinc is also attached to the side chain of GIu-270, 
which is rotated 22° with respect to the native structure in 
order to coordinate in a monodentate manner to the inhibi-
tory zinc through the side-chain oxygen Od (Fig. 2). Addi-
tionally, a second strong electron density peak within ligation 
distance to the inhibitory zinc ion (labelled 998) was assigned 
to a chloride ion (labelled 501, B=22 A..2 ). There were two 
good reasons to consider Cl- as the coordinating anion, the 
presence of Cl- (LiCI and ZnCh) in the crystallization con-
ditions and the observation that the species Zn(OH)CI has a 
net charge of 0, the same as the neutral molecule (W571) that 
it substitutes. This possibility has also been suggested by Lar-
sen and Auld [12,13] on the basis of enzyme inhibition studies 
Table I 
X-ray data collection and processing 
Diffraction data 
No. of measured reflections 
No. of unique reflections 
Rmergea 
Completeness 
for data (25-1.7 A) 
Refinement 
initial R factor 
final R factor 
rms deviation from ideal values 
58729 
29901 
0.082 
92.9% 
25.2% 
18.7% 
bonds 0.009 A 
bond angles 1.474 A 
planarity 23.974 A 
aRmerge= IIII(h),- <I(h) > IIL<I(h»; I(h); is the observed inten-
sity of the i-th measurement of reflection h, and < I(h) > the mean 
intensity of reflection h; calculated after loading, scaling, and merging 
of Friedel pairs with rotavata/agrovata (CCP4 [2ID. 
with Zn(II), Pb(lI) and Cd (II) by kinetic and electronic ab-
sorption spectra approaches. Besides binding to water/hydrox-
ide W571b, Glu-270 Od and Cl-501, the inhibitory zinc is 
also bound to water W481, establishing an overall tetrahedral 
(distorted) coordination with them. The interatomic distances 
between the inhibitory zinc and the ligands are all around the 
typical zinc ion-ligand values (1.8-2.4 A..) (Table 2) [25-28). 
The angles are also within the ranges reported in the litera-
ture. From the point of view of charges in the model that we 
propose at pH 7.5, the two-zinc ion cluster displays 4 positive 
charges (due to both metal ions) and three formal negative 
charges (Glu-n, Glu-270 and Cl-(501». The suggested hy-
Table 2 
Crystallographic distances between the catalytic (I) and the inhibi-
tory (2) zinc ions in CPA+Zn and their ligands: comparison with 
the CPA and CPA + Bzx structures 
CPA [3] CPA+excess Zn2+ CPA [31]+Bzxa 
Zn (I) 
Glu-72 oel 2.18 2.10 2.03 
Glu-72 oe2 2.31 2.17 2.75 
His-69 Wi 2.12 1.93 2.04 
His-l96 Nel 2.07 2.08 2.00 
W571 2 205 
W5672 3.23 
W571b 2.36 
5000el 2.31 
5000e2 2.61 
Zn (2) 
Glu-270 ocl 1.86 
CQ501) 2.29 
W571b 2.17 
W481 2.39 
aBzx, substrate-analog inhibitor benzyl succinic acid [31]. 
bW571 and W567 are alternative sites occupied by a single water [3]. 
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droxide ion W 571 b compensates the residual charge as is the 
case in many metal ion clusters [29]. 
To elucidate the inhibition of CPA by the second zinc, we 
have overlapped the structures of the enzyme active site de-
rived from CPA+Zn (this work) and from CPA+benzylsucci-
nic acid [30] where benzyl succinic acid is a competitive inhib-
itor of CPA [6] and is supposed to occupy a similar position 
as the peptide bond to be cleaved. The superimposition of 
both structures shows that the respective positions of the car-
bonyl group (500C [30]) of the inhibitor and the inhibitory 
zinc ion are almost the same (Table 2). The second zinc will 
thus interfere with the proper positioning of the substrates at 
the active site of CPA. 
It has been previously proposed that Glu-218 and His-303 
could be responsible for binding excess inhibitory zinc [31]. 
We have not found any electron density near these residues 
which could be ascribed to a bound zinc. In contrast, our 
results strongly support the experimental results and hypo-
thesis of Larsen and Auld [12,13] which point to the establish-
ment of a mono hydroxide bridge between the catalytic and 
the inhibitory zinc and the coordination of the latter to Glu-
270. 
3.2. Inhibition by excess zinc in other metalloproteases 
Recently the crystal structure of the metalloendoprotease 
thermolysin in the presence of excess zinc has been reported 
[18]. Despite the great differences in overall folding, zinc bind-
ing motifs and active-site topologies between this enzyme and 
CPA, both main representatives of two large subfamilies -
exoproteases and endoproteases - within the zinc proteases, 
both enzymes have in common an essential - catalytic - zinc 
(II) ion at the active site. This essential zinc ion is bound in a 
tetrahedral coordination and plays a similar role in the pro-
teolysis of substrates [32,33]. In thermolysin, the catalytic zinc 
ion is coordinated by two histidines (His-142 and His-146), 
one glutamate (Glu-166) and one water molecule (W231). 
In the presence of excess of zinc, the crystal structure of 
thermo lysin also shows a second - inhibitory - zinc bound to 
the active site [18]. A comparison of the features of the second 
zinc binding site in this structure and in the CPA+Zn struc-
ture is noteworthy: (l) the two zincs are at similar distances in 
both enzymes, 3.2 A in thermolysin and 3.3 A in CPA; (2) a 
water/hydroxide ligand is observed as a bridge of similar geo-
metry with a Zn-O-Zn angle of 116° in thermolysin and of 
114° in CPA; (3) in thermolysin the inhibitory zinc is tetra-
hedrally coordinated to Tyr-157, His-231, Wl43 and Glu-166. 
This residue (Glu-166) is also a ligand of the catalytic zinc 
and, therefore, establishes a second bridge between the two 
zinc ions. This is not the case in CPA+Zn in which the ligands 
for the catalytic and the inhibitory zinc are different. 
Interestingly, the coordination of the inhibitory zinc in CPA 
constitutes a new type of zinc binding site, because this metal 
has always been found coordinated with at least one imidazole 
group [1,32]. On the other hand, the two inhibitory zinc bind-
ing sites, in CPA and thermolysin, share many features with 
the cocatalytic motif in multizinc enzymes [33], where the 
participating metal atoms are in close proximity (3-5 A) 
and function as a catalytic unit. This is the case, e.g. in alka-
line phosphatase, phospholipase C, nuclease PI, lens amino-
peptidase, superoxide dismutase [34]. The occurrence of a 
bridging ligand, aspartate, glutamate, and/or a water molecule 
or hydroxide ion, is the most significant feature of these co-
339 
catalytic sites and is distinctive in differentiating the cocataly-
tic from the catalytic and structural sites. 
It would be of interest to extend these detailed structural 
comparative studies to other zinc metalloenzymes in order to 
improve our knowledge of the chemistry of isolated and clus-
tered zincs in these enzymes and their potential involvement in 
regulatory and toxicological processes. In this respect, it could 
be added that free Zn2+ concentrations in human body ranges 
from nanomolar to micromolar concentrations in the cyto-
plasm, in normal states, to much higher concentrations in 
certain vesicles and fluids or in abnormal/toxicological states 
[1,35]. The potential influence of these zinc ions on the activity 
of metalloenzymes in general, and in tissue metallo-carboxy-
peptidases - involved in important physiological functions [6] 
- in particular, cannot be neglected. 
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